Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

2(40%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

20%

Ph phase_2

20%

Ph phase_3

40%

Ph phase_4

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

1(20.0%)

Phase 3Large-scale testing

2(40.0%)

Phase 4Post-market surveillance

1(20.0%)

N/ANon-phased studies

1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Other(1)

Detailed Status

Completed2

Recruiting2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (20.0%)

Phase 32 (40.0%)

Phase 41 (20.0%)

N/A1 (20.0%)

Trials by Status

completed240%

recruiting240%

unknown120%

Recent Activity

2 active trials

Showing 5 of 5

recruitingphase_3

The Use of Antimicrobial Agents in the Inhibition of Mutans Streptococci in Children With Dental Caries

NCT00612469

Clinical Trials (5)

Showing 5 of 5 trials

NCT05766670Phase 3

Intramedullary Calcium Sulfate Antibiotic Depot

Recruiting

NCT04500275Phase 4

Topical Vancomycin Over Sternal Edge in Cardiac Surgery

Completed

NCT06126614Phase 3

Infection Prophylaxis in Total Joint Replacement

Recruiting

NCT03221023Phase 2

Intrawound Vancomycin Prophylaxis for Neural Stimulator

Unknown

NCT00612469Not Applicable

The Use of Antimicrobial Agents in the Inhibition of Mutans Streptococci in Children With Dental Caries

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5